|Table of Contents|

Combined hepatectomy and radiofrequency ablation for multifocal liver cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2017 01
Page:
82-86
Research Field:
Publishing date:

Info

Title:
Combined hepatectomy and radiofrequency ablation for multifocal liver cancer
Author(s):
Zeng Xintao; Yang Pei; Luo Hua; Zhang Wei; Guo Daoning; Chen Xi
Department of Hepatobiliary Surgery，Mianyang Central Hospital，Sichuan Mianyang 621000，China.
Keywords:
liver cancer; radiofrequency ablation; intraoperative ultrasound; hepatectomy
PACS:
R735.7；R730.5
DOI:
10.3969/j.issn.1672-4992.2017.01.023
Abstract:
Objective：To discuss the feasibility and safety of hepatectomy combined with radiofrequency ablation (RFA）for multifocal liver cancers.Methods：There were 42 patients with multifocal hepatocellular carcinomas (HCCs） were found preoperation by ultrasound，CT or MRI，and 9 focus were found intraoperative.7 cases undergoing hemihepatectomy，2 patients performed posterior lobes resection and 27 cases undergoing local excision.49 Lesions were resected.There were 72 focus managed by RFA，We conducted contrast-enhanced ultrasound (CEUS） routinely intraoperation.Results：All patients undergoing surgical procedure successfully.Excision time was 14~45min （25.1±12.8）min.Single lesion RFA time was 9~37min (17.2±11.9）min and total RFA time was 16~61min (36.4±19.2）min.Total operation time was 73~189min (138.2±76.6）min.Blood loss was 80~1 100ml (429.7±226.5）ml.No liver and kidney function failure or vice-damage happened.When the virus reach 5.00E+2IU/ml，the patients accepted antiviral treatment after operation seven days.All cases need accept transcatheter arterial chemoembolization (TACE) one month later.There were 2 cases loss to follow-up，follow-up time was 6~103months (49.2±31.8）months.Conclusion：Surgical resection combined with RFA therapy can preserve impaired liver functions，also can improve resectability，it is feasible，safe and effective.

References:

［1］Taniai N，Yoshida H，Yoshioka M.Surgical outcomes and prognostic factors in elderly patients (75 years old）with hepatocellular carcinoma who underwent hepatectomy［J］.J Nippon Med Sch，2013，80(6)：426-432.
［2］Jia CK，Weng J，Chen YK.Anatomic resection of liver segments 6-8 for hepatocellular carcinoma［J］.World J Gastroenterol，2014，20(15)：4433-4439.
［3］Iliescu L，Mindrut E，Grasu M，et al.Management of hepatocellular carcinoma-experience of a single center［J］.Chirurgia(Bucur)，2014，109(2)：204-207.
［4］J Bruix，AJ Hessheimer，A Forner.New aspects of diagnosis and therapy of hepatocellular carcinoma［J］.Oncogene，2006，25：3848-3856.
［5］Davendra PS Sohal，Weijing Sun.Hepatocellular carcinoma：prevention and therapy［J］.Curr Oncol Rep，2011，13：186-194.
［6］Xu XS，Liu C，Qu K.Liver transplantation versus liver resection for hepatocellular carcinoma：a meta-analysis［J］.Hepatobiliary Pancreat Dis Int，2014，13(3)：234-241.
［7］Feng K，Ma KS.Value of radiofrequency ablation in the treatment of hepatocellular carcinoma［J］.World J Gastroenterol，2014，20(20)：5987-5998.
［8］Duan C，Liu M，Zhang Z.Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria：a systematic review and meta-analysis［J］.World J Surg Oncol，2013，11(1)：190.
［9］Peng ZW，Liu FR，Ye S，et al.Radiofrequency ablation versus open hepatic resection for elderly patients (>65 years old） with very early or early hepatocellular carcinoma［J］.Cancer，2013，119(21)：3812-3820.
［10］Liu CL，Fan ST，Lo CM，et al.Hepatic resection for bilobar hepatocellular carcinoma：is it justified［J］?Arch Surg，2003，138(1)：100-104.
［11］Ferrero A，Langella S.Intraoperative liver ultrasound still affects surgical strategy for patients with colorectal metastases in the modern era［J］.World J Surg，2013，37(11)：2655-2663.
［12］L Bonannia，N de'Liguori Carinoa，R Deshpande.A comparison of diagnostic imaging modalities for colorectal liver metastases［J］.Eur J Surg Oncol，2014，40(5)：545-550.
［13］Mathieu D'Hondt，Franck Vandenbroucke-Menu，Sébastien Préville-Ratelle，et al.Is intra-operative ultrasound still useful for the detection of a hepatic tumour in the era of modern pre-operative imaging［J］.HPB(Oxford)，2011，13(9)：665-669.
［14］Yan Q，Ni J，Zhang GL，et al.Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence［J］.Chin Med J(Engl)，2013，126(5)：855-859.
［15］Ke Y，Ma L，You XM，et al.Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy［J］.Cancer Biol Med，2013，10(3)：158-164.

Memo

Memo:
-
Last Update: 2016-12-01